BCYC — Bicycle Therapeutics Share News
0.000.00%
Last trade - 00:00- $267.37m
- -$241.92m
- $72.59m
Brief: Bicycle Therapeutics PLC Felix J. Baker To Become Chairman Of Board Of Directors
Brief: Eckert & Ziegler Enters Partnership With Bicycle Therapeutics
Bicycle Therapeutics PLC reports results for the quarter ended December 31 - Earnings Summary
Bicycle Therapeutics PLC expected to post a loss of 86 cents a share - Earnings Preview
Bicycle Therapeutics PLC reports results for the quarter ended in September 30 - Earnings Summary
Brief: Bicycle Therapeutics PLC Expected Financial Runway Into 2H 2027
Bicycle Therapeutics PLC expected to post a loss of 78 cents a share - Earnings Preview
Filed A Prospectus Supplement With Respect To Resale By Selling Securityholders
Bicycle Therapeutics PLC reports results for the quarter ended in March - Earnings Summary
Bicycle Therapeutics PLC expected to post a loss of $1.24 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-JetBlue Airways, LPL Financial, Nvidia
U.S. STOCKS ON THE MOVE-Bicycle Therapeutics, Molson Coors, LianBio
Bicycle Therapeutics jumps as Baker Bros boosts stake
Bicycle Therapeutics PLC reports results for the quarter ended in September - Earnings Summary
Bicycle Therapeutics PLC expected to post a loss of $1.17 a share - Earnings Preview
Brief: Bicycle Therapeutics Says Announces Expedited Development Plan For Bt8009 In Metastatic Bladder Cancer
Bicycle Therapeutics PLC reports results for the quarter ended in June - Earnings Summary
Brief: Bicycle Therapeutics plc Q2 Pretax Profit USD -43.12 Mln
Bicycle Therapeutics PLC expected to post a loss of $1.29 a share - Earnings Preview